We are live on ! Find out more
TRHC

Tabula Rasa HealthCare, Inc. Common Stock

Delisted

TRHC was delisted on the 2nd of November, 2023.

184 hedge funds and large institutions have $1.08B invested in Tabula Rasa HealthCare, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 100 increasing their positions, 36 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

178% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 36

64% more call options, than puts

Call options by funds: $4.87M | Put options by funds: $2.98M

3% more capital invested

Capital invested by funds: $1.05B → $1.08B (+$32.3M)

5% less funds holding

Funds holding: 194184 (-10)

25% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 32

Holders
184
Holders Change
-10
Holders Change %
-5.15%
% of All Funds
4%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
24
Increased
100
Reduced
36
Closed
32
Calls
$4.87M
Puts
$2.98M
Net Calls
+$1.9M
Net Calls Change
-$9.08M
Name Holding Trade Value Shares
Change
Change in
Stake
JWA
176
JFS Wealth Advisors
Pennsylvania
$5K
PCP
177
Proficio Capital Partners
Massachusetts
$5K +$4.63K +93 New
CFGS
178
Concourse Financial Group Securities
Alabama
$3K +$1.19K +24 +60%
TRCT
179
Tower Research Capital (TRC)
New York
$3K +$3.38K +68 New
Carson Wealth (CWM LLC)
180
Carson Wealth (CWM LLC)
Nebraska
$2K
TWA
181
TCI Wealth Advisors
Arizona
$2K
US Bancorp
182
US Bancorp
Minnesota
$1K -$15.1K -303 -92%
PFBT
183
Parkside Financial Bank & Trust
Missouri
$1K +$547 +11 +85%
GT
184
Glenmede Trust
Pennsylvania
$2
Capital Research Global Investors
185
Capital Research Global Investors
California
-$19.8M -350,340 Closed
CAM
186
Cortina Asset Management
Wisconsin
-$6.21M -110,063 Closed
NCGI
187
Next Century Growth Investors
Minnesota
-$4.69M -83,098 Closed
NIP
188
Nicholas Investment Partners
California
-$4.44M -78,753 Closed
FA
189
Friess Associates
Delaware
-$2.1M -37,233 Closed
PAM
190
Panagora Asset Management
Massachusetts
-$1.08M -19,136 Closed
MWNA
191
Marshall Wace North America
New York
-$992K -17,575 Closed
SCM
192
Sterling Capital Management
North Carolina
-$963K -17,069 Closed
QT
193
Quantbot Technologies
New York
-$744K -13,200 Closed
SO
194
STRS Ohio
Ohio
-$660K -11,700 Closed
IAA
195
Independent Advisor Alliance
North Carolina
-$588K -10,415 Closed
TI
196
Trexquant Investment
Connecticut
-$584K -10,347 Closed
Truist Financial
197
Truist Financial
North Carolina
-$442K -7,828 Closed
GAM
198
Gotham Asset Management
New York
-$417K -7,389 Closed
VF
199
Virtu Financial
New York
-$326K -5,778 Closed
BLA
200
Balter Liquid Alternatives
Massachusetts
-$304K -5,390 Closed

TRHC Hedge Fund Activity: Q2 2019 in Review

184 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Tabula Rasa HealthCare, Inc. Common Stock (TRHC) for Q2 2019, worth a combined $1.08B — up 3.1% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of TRHC and 24 opened new positions — a net loss of 8 holders — while 36 trimmed existing stakes and 100 added.

The largest buyer was Artisan Partners, adding an estimated $20.1M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $19.8M sold.

  • 184 institutional investors held Tabula Rasa HealthCare, Inc. Common Stock (TRHC) as of Q2 2019, down from 194 in Q1 2019.
  • Funds reported $1.08B of Tabula Rasa HealthCare, Inc. Common Stock stock for Q2 2019, up 3.1% quarter-over-quarter.
  • 24 funds opened new Tabula Rasa HealthCare, Inc. Common Stock positions in Q2 2019 and 32 closed out, a net change of -8 holders.
  • The largest Tabula Rasa HealthCare, Inc. Common Stock buyer in Q2 2019 was Artisan Partners, an estimated $20.1M added.
  • The largest Tabula Rasa HealthCare, Inc. Common Stock seller in Q2 2019 was Capital Research Global Investors, an estimated $19.8M sold.

Based on aggregated 13F filings for Q2 2019.